CBOE · US Equities - US Style · USA
The companies inside CVAR trade 15% below what we estimate they are worth. We could give a verdict on 79% of the fund's weight: 90 holdings as reported to the SEC at 31 Jul 2026.
Where the money is: 26% in companies in the buy zone, 14% about fairly valued, 38% overvalued, 21% without a verdict.
The ten largest holdings, with our verdict on each:
Its expense ratio is 0.87% a year: on $10,000 held flat that is $870 over 10 years and $1,740 over 20.